← Back to headlines
UniQure to Seek FDA Approval for Huntington's Gene Therapy
UniQure plans to submit a U.S. marketing application to the FDA for its Huntington's disease gene therapy. This move follows a previous disagreement with the agency regarding the treatment.
17 Jun, 11:35 — 17 Jun, 16:12
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual53d ago
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
Read full article →seeking-alphaMixed53d ago
uniQure to submit U.S. marketing application for gene therapy
Read full article →Coverage Timeline
First report: seeking-alpha · 17 Jun, 11:35|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
